Document Detail


Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?
MedLine Citation:
PMID:  23463541     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Hyperglycemia is considered to be the major cause of microvascular complications of diabetes. Growing evidence highlights the importance of hyperglycemia-mediated inflammation in the initiation and progression of microvascular complications in type 1 diabetes. We hypothesize that lack of proinsulin C-peptide and lack of its anti-inflammatory properties contribute to the development of microvascular complications. Evidence gathered over the past 20 years shows that C-peptide is a biologically active peptide in its own right. It has been shown to reduce formation of reactive oxygen species (ROS) and nuclear factor (NF)-⊇B activation induced by hyperglycemia, resulting in inhibition of cytokine, chemokine and cell adhesion molecule formation as well as reduced apoptotic activity. In addition, C-peptide stimulates and induces the expression of both Na+ , K+ -ATPase and endothelial nitric oxide synthase (eNOS). Animal studies and small-scale clinical trials in type 1 diabetes patients suggest that C-peptide replacement combined with regular insulin therapy exerts beneficial effects on kidney and nerve dysfunction. Further clinical trials in patients with microvascular complications including measurements of inflammatory markers are warranted to explore the clinical significance of the above, previously unrecognized, C-peptide effects. Copyright © 2013 John Wiley & Sons, Ltd.
Authors:
Patrizia Luppi; Asa Kallas; John Wahren
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-3-6
Journal Detail:
Title:  Diabetes/metabolism research and reviews     Volume:  -     ISSN:  1520-7560     ISO Abbreviation:  Diabetes Metab. Res. Rev.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-3-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883450     Medline TA:  Diabetes Metab Res Rev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 John Wiley & Sons, Ltd.
Affiliation:
Division of Immunogenetics, Department of Pediatrics, Children´s Hospital of Pittsburgh of UPMC, Rangos Research Center, Pittsburgh, PA, 15201, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A mathematical model of the coupled mechanisms of cell adhesion, contraction and spreading.
Next Document:  Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-...